• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Shire PLC ADR

Shire PLC ADR

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. ETFs and Mutual Funds: Why not both?

    Shire Pharmaceuticals SHPGY recently announced that the FDA approved its Hunter syndrome therapy, Elaprase, for marketing. We're slightly raising our fair value estimate to account for this new addition to Shire's product portfolio. Shire received rights to Elaprase, a human enzyme replacement ...

  2. EUROPE MARKETS: European Stocks Edge Up As ECB Cuts Rates

    EUROPE MARKETS: European Stocks Edge Up As ECB Cuts Rates

Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.